Fibrinolysis is regulated by specific molecular interactions between its main components. Activation of plasminogen by tissue-type plasminogen activator (t-PA) is enhanced in the presence of fibrin or at the endothelial cell surface. Urokinase-type plasminogen activator (u-PA) binds to a specific cellular u-PA receptor (u-PAR), resulting in enhanced activation of cell-bound plasminogen. Inhibition of fibrinolysis occurs at the level of plasminogen activation or at the level of plasmin. Assembly of fibrinolytic components at the surface of fibrin results in fibrin degradation. Assembly at the surface of cells provides a mechanism for generation of localized cell-associated proteolytic activity. This review includes novel proteins such a thrombin-activatable fibrinolysis inhibitor (TAFI) and discusses new insights into molecular mechanisms obtained from the rapidly growing knowledge of crystal structures of proteins.

, , , , ,,
Journal of Thrombosis and Haemostasis
Erasmus MC: University Medical Center Rotterdam

Rijken, D., & Lijnen, H. R. (2009). New insights into the molecular mechanisms of the fibrinolytic system. Journal of Thrombosis and Haemostasis (Vol. 7, pp. 4–13). doi:10.1111/j.1538-7836.2008.03220.x